Gestational diabetes mellitus modulates neonatal high-density lipoprotein composition and its functional heterogeneity.

[1]  Chang Yeop Han,et al.  Thematic review series : The Immune System and Atherogenesis Lipoprotein-associated inflammatory proteins : markers or mediators of cardiovascular disease ? , 2005 .

[2]  H. Ortega,et al.  Maternal Lipid Metabolism and Placental Lipid Transfer , 2006, Hormone Research in Paediatrics.

[3]  K. Resing,et al.  Comparison of Label-free Methods for Quantifying Human Proteins by Shotgun Proteomics*S , 2005, Molecular & Cellular Proteomics.

[4]  A. Kontush,et al.  Proteomic Analysis of Defined HDL Subpopulations Reveals Particle-Specific Protein Clusters: Relevance to Antioxidative Function , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[5]  M. Bouchenak,et al.  Maternal and fetal serum lipid and lipoprotein concentrations and compositions in type 1 diabetic pregnancy: relationship with maternal glycemic control. , 2000, The Journal of laboratory and clinical medicine.

[6]  G. Getz,et al.  HDL content and composition in acute phase response in three species: triglyceride enrichment of HDL a factor in its decrease. , 1996, Journal of lipid research.

[7]  M. Saemann,et al.  Inflammation alters HDL composition and function: implications for HDL-raising therapies. , 2013, Pharmacology & therapeutics.

[8]  O. Erel.  A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. , 2003, Clinical biochemistry.

[9]  A. Yessoufou,et al.  Maternal Diabetes in Pregnancy: Early and Long-Term Outcomes on the Offspring and the Concept of “Metabolic Memory” , 2011, Experimental diabetes research.

[10]  E. Ryan.  Diagnosing gestational diabetes , 2011, Diabetologia.

[11]  R. Munford,et al.  Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins Published, JLR Papers in Press, August 16, 2003. DOI 10.1194/jlr.M300228-JLR200 , 2003, Journal of Lipid Research.

[12]  B. Gordon,et al.  A single intravenous dose of endotoxin rapidly alters serum lipoproteins and lipid transfer proteins in normal volunteers Published, JLR Papers in Press, May 16, 2003. DOI 10.1194/jlr.M200440-JLR200 , 2003, Journal of Lipid Research.

[13]  H. C. Dreyer,et al.  Diabetes in Early Pregnancy: Getting to the Heart of the Matter , 2012, Diabetes.

[14]  A. Levy,et al.  HDL dysfunction in diabetes: causes and possible treatments , 2012, Expert review of cardiovascular therapy.

[15]  M. Jauhiainen,et al.  Phospholipid transfer protein is differentially expressed in human arterial and venous placental endothelial cells and enhances cholesterol efflux to fetal HDL. , 2012, The Journal of clinical endocrinology and metabolism.

[16]  V. Kakkar,et al.  Friend Turns Foe: Transformation of Anti-Inflammatory HDL to Proinflammatory HDL during Acute-Phase Response , 2010, Cholesterol.

[17]  M. Battin,et al.  Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU) , 2011, Diabetes Care.

[18]  C. Napoli,et al.  The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol‐lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes. , 2001, Obstetrics and gynecology.

[20]  M. Tremblay,et al.  Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans: in vivo evidence for a link between HDL apoC-III and apoA-I metabolism. , 2003, Journal of lipid research.

[21]  K. Godfrey,et al.  Maternal Diet During Pregnancy and Carotid Intima–Media Thickness in Children , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[22]  Baohai Shao.  Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by ABCA1, a key cardioprotective function of HDL. , 2012, Biochimica et biophysica acta.

[23]  E. Sobngwi,et al.  Consequences of fetal exposure to maternal diabetes in offspring. , 2006, The Journal of clinical endocrinology and metabolism.

[24]  P. Puddu,et al.  Association of serum C3 levels with the risk of myocardial infarction. , 1995, The American journal of medicine.

[25]  P. Oszukowski,et al.  [C-reactive protein in normal pregnancy]. , 1996, Ginekologia polska.

[26]  C. Reardon,et al.  Thematic review series: The Immune System and Atherogenesis. The unusual suspects: Published, JLR Papers in Press, March 16, 2005. DOI 10.1194/jlr.R500003-JLR200an overview of the minor leukocyte populations in atherosclerosis , 2005, Journal of Lipid Research.

[27]  B. Dahlbäck,et al.  Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M , 2011, Proceedings of the National Academy of Sciences.

[28]  P. Catalano,et al.  Association of existing diabetes, gestational diabetes and glycosuria in pregnancy with macrosomia and offspring body mass index, waist and fat mass in later childhood: findings from a prospective pregnancy cohort , 2009, Diabetologia.

[29]  D. Gaudet,et al.  Dyslipidemia of Mothers With Familial Hypercholesterolemia Deteriorates Lipids in Adult Offspring , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[30]  H. Hackl,et al.  Fetal HDL/apoE: a novel regulator of gene expression in human placental endothelial cells. , 2011, Physiological genomics.

[31]  Z. Tabka,et al.  Antioxidant status and circulating lipids are altered in human gestational diabetes and macrosomia. , 2007, Translational research : the journal of laboratory and clinical medicine.

[32]  M. Kilby,et al.  Fetal and maternal lipoprotein metabolism in human pregnancy complicated by type I diabetes mellitus. , 1998, The Journal of clinical endocrinology and metabolism.

[33]  E. Ferrannini,et al.  Anti-inflammatory and Antioxidant Properties of HDLs Are Impaired in Type 2 Diabetes , 2011, Diabetes.

[34]  E. Korgun,et al.  Human fetal placental endothelial cells have a mature arterial and a juvenile venous phenotype with adipogenic and osteogenic differentiation potential. , 2008, Differentiation; research in biological diversity.

[35]  S. Hammad,et al.  High Density Lipoprotein-associated Sphingosine 1-Phosphate Promotes Endothelial Barrier Function* , 2008, Journal of Biological Chemistry.

[36]  G. Desoye,et al.  Antibody reaction patterns in first trimester placenta: implications for trophoblast isolation and purity screening. , 2000, Placenta.

[37]  D. Barker.  Fetal origins of coronary heart disease , 1995, BMJ.

[38]  H. Scharnagl,et al.  Distinct composition of human fetal HDL attenuates its anti-oxidative capacity. , 2013, Biochimica et biophysica acta.

[39]  Kunihiko Kobayashi,et al.  Unique character and metabolism of high density lipoprotein (HDL) in fetus. , 2002, Atherosclerosis.

[40]  U. Lang,et al.  Human Endothelial Cells of the Placental Barrier Efficiently Deliver Cholesterol to the Fetal Circulation via ABCA1 and ABCG1 , 2009, Circulation research.

[41]  E. Dubé,et al.  Modulation of Cholesterol Transport by Insulin-Treated Gestational Diabetes Mellitus in Human Full-Term Placenta1 , 2013, Biology of reproduction.

[42]  L. Silengo,et al.  Structure of the human hemopexin gene and evidence for intron-mediated evolution , 2005, Journal of Molecular Evolution.

[43]  E. Dennis,et al.  Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. , 1999, The Journal of clinical investigation.

[44]  Robert L Wilensky,et al.  Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. , 2011, The New England journal of medicine.

[45]  M. Tremblay,et al.  Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans Published, JLR Papers in Press, July 16, 2003. DOI 10.1194/jlr.M300209-JLR200 , 2003, Journal of Lipid Research.